CRSP
CRISPR Therapeutics AG · Healthcare
CEO Samarth Kulkarni sold $1.6M of CRISPR Therapeutics AG
Sold$1,607,177
$80.36Price
20,000Shares
−5%Stake
What CRSP did after the filing
- The stock from Fri, Feb 16 close, $82.22
- −20.9%
- S&P 500, same days
- +4.2%
Measured over 30 trading days, to the Apr 2 close.
Traded Thu, Feb 15. Filed Fri, Feb 16, 12:45 PM ET, during the session. Returns use the Feb 16 close and the Apr 2 close. Not investment advice.